Combination of N-methyl-1-deoxynojirimycin and ischemic preconditioning markedly reduces the size of myocardial infarcts in rabbits

Japanese Circulation Journal

Volumn 65, Issue 7, 2001, Pages 673-677

  Wu, D J ^a   Minatoguchi, S ^a   Uno, Y ^a   Arai, M ^a   Wang, N ^a   Nishida, Y ^a   Hashimoto, K ^a   Hashimoto, Y ^a   Takemura, G ^a   Fujiwara, T ^a   Fujiwara, H ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

glucosidase inhibitor; Glycogen; Ischemia; Myocardial infarction; Myocardium

Indexed keywords

1 DEOXY N METHYLNOJIRIMYCIN; DEXTRANASE; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOGEN; LACTIC ACID; PHOSPHORYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; GLYCOGENOLYSIS; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; RABBIT;

1-DEOXYNOJIRIMYCIN; ALPHA-GLUCOSIDASES; ANIMALS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GLYCOGEN; HEART VENTRICLES; ISCHEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LACTIC ACID; MYOCARDIAL INFARCTION; RABBITS;

EID: 0034929471     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.673     Document Type: Article

References (34)

1. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia
2. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning
3. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
4. Ischemic preconditioning reduces infarct size in swine myocardium
5. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: Retrospective clinical evidence of 'preconditioning'
6. Protection against infarction afforded by preconditioning is mediated by Aadenosine receptors in rabbit heart
7. Infarct size-reducing effect of ischemic preconditioning is related to alb-adrenoceptors but not to ala-adrenoceptors in rabbits
8. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts
9. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischemic preconditioning in the rabbit
10. Preconditioning protects ischemic rabbit heart by protein kinase C activation
11. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
12. Ischemic preconditioning preserves creatine phosphate and intracellular pH
13. Energy metabolism in preconditioned and control myocardium: Effect of total ischemia
14. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode
15. N-methyl-l-deoxynojirimycin (MOR-14), an a-glucosidase inhibitor, markedly reduced infarct size in rabbit hearts
16. Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique
17. Early ischemia after complete coronary ligation in the rabbit, dog, pig, and monkey
18. The antiglycogenolytic action of 1-deoxynojirimycin results from a specific inhibition of the α-1,6-glucosidase activity of the debranching enzyme
19. Determination of buffering capacity of rat myocardium during ischemia
20. Role of glycolytic products in damage to ischemic myocardium: Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts
21. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment
22. Does preconditioning act by glycogen depletion in the isolated rat heart?
23. Does glycogen depletion play an important role in ischemic preconditioning?
24. Ischemic preconditioning in rat heart: No correlation between glycogen content and return of function
25. Role of preischemic glycogen depletion in the improvement of postischemic metabolic and contractile recovery of ischemia-preconditioned rat hearts
26. Improved myocardial tolerance to ischaemia in the diabetic rabbit
27. Glycogen depletion contributes to ischemic preconditioning in the rat heart in vivo
28. Assessment of glycogen turnover in aerobic, ischemic, and reperfused working rat hearts
29. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes
30. Protein kinase C mediates MOR-14-induced cardioprotection
31. 1-deoxynojirimycin and related compounds inhibit glycogenolysis in the liver without affecting the concentration of phosphorylase a
32. Inhibition of intestinal a-glucosidase activity and postgrandial hyperglycemia by moranoline and its N-alkyl derivatives